Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk

Curr Vasc Pharmacol. 2019;17(6):610-617. doi: 10.2174/1570161117666190408165805.

Abstract

Vitamin D and calcium are considered crucial for the treatment of bone diseases. Both vitamin D and calcium contribute to bone homeostasis but also preserve muscle health by reducing the risk of falls and fractures. Low vitamin D concentrations result in secondary hyperparathyroidism and contribute to bone loss, although the development of secondary hyperparathyroidism varies, even in patients with severe vitamin D deficiency. Findings from observational studies have shown controversial results regarding the association between bone mineral density and vitamin D/calcium status, thus sparking a debate regarding optimum concentrations of 25-hydroxyvitamin D and calcium for the best possible skeletal health. Although most of the intervention studies reported a positive effect of supplementation with calcium and vitamin D on bone in patients with osteoporosis, this therapeutic approach has been a matter of debate regarding potential side effects on the cardiovascular (CV) system. Thus, the aim of this review is to consider the current evidence on the physiological role of vitamin D and calcium on bone and muscle health. Moreover, we provide an overview on observational and interventional studies that investigate the effect of vitamin D and calcium supplementation on bone health, also taking into account the possible CV side-effects. We also provide molecular insights on the effect of calcium plus vitamin D on the CV system.

Keywords: Vitamin D; bone health; calcium; cardiovascular system; myocardial infarction; stroke..

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / blood
  • Bone Remodeling / drug effects*
  • Calcium / adverse effects
  • Calcium / blood
  • Calcium / therapeutic use*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / prevention & control*
  • Cardiovascular System / drug effects*
  • Cardiovascular System / metabolism
  • Cardiovascular System / physiopathology
  • Dietary Supplements / adverse effects
  • Humans
  • Hyperparathyroidism, Secondary / blood
  • Hyperparathyroidism, Secondary / drug therapy*
  • Hyperparathyroidism, Secondary / epidemiology
  • Hyperparathyroidism, Secondary / physiopathology
  • Osteoporosis / blood
  • Osteoporosis / drug therapy*
  • Osteoporosis / epidemiology
  • Osteoporosis / physiopathology
  • Osteoporotic Fractures / epidemiology
  • Osteoporotic Fractures / physiopathology
  • Osteoporotic Fractures / prevention & control
  • Risk Factors
  • Treatment Outcome
  • Vitamin D / adverse effects
  • Vitamin D / blood
  • Vitamin D / therapeutic use*
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / drug therapy*
  • Vitamin D Deficiency / epidemiology
  • Vitamin D Deficiency / physiopathology

Substances

  • Biomarkers
  • Vitamin D
  • Calcium